Skip to main content
Kevin Kuntz, MD, Psychiatry, Madison, WI

Kevin D Kuntz MD


Associate Professor, Psychiatry, University of Wisconsin Medical School

Join to View Full Profile
  • 406 Science DrSuite 110Madison, WI 53711

  • Phone+1 608-238-4411

  • Fax+1 608-287-5992

Are you Dr. Kuntz?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Kevin Kuntz, MD is a board certified psychiatrist in Madison, Wisconsin. He is currently licensed to practice medicine in Wisconsin, Vermont, and Vermont. He is an Associate Professor at University of Wisconsin Medical School.

Education & Training

  • University of Vermont Medical Center
    University of Vermont Medical CenterResidency, Psychiatry, 1990 - 1994
  • University of Iowa Roy J. and Lucille A. Carver College of Medicine
    University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1990

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 1994 - 2025
  • VT State Medical License
    VT State Medical License 1990 - 1994
  • VT State Medical License
    VT State Medical License 1990 - 1994
  • Psychiatry
    American Board of Psychiatry and Neurology Psychiatry

Press Mentions

  • Ziopharm Finds New CEO After Six-Month Search; CFO Transition at Lonza to Take Place in December
    Ziopharm Finds New CEO After Six-Month Search; CFO Transition at Lonza to Take Place in DecemberSeptember 3rd, 2021
  • Ribon Therapeutics Presents Additional Preclinical Data on Its PARP7 Inhibitor – RBN-2397 – and Demonstrates Broad Potential of Its Platform at the AACR 2020 Virtual Meeting II
    Ribon Therapeutics Presents Additional Preclinical Data on Its PARP7 Inhibitor – RBN-2397 – and Demonstrates Broad Potential of Its Platform at the AACR 2020 Virtual Meeting IIJune 22nd, 2020
  • Ribon Therapeutics Presents Preclinical Data from Its PARP7 and PARP14 Programs at AACR Virtual Meeting I
    Ribon Therapeutics Presents Preclinical Data from Its PARP7 and PARP14 Programs at AACR Virtual Meeting IApril 27th, 2020